The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in <i>App<sup>NL-G-F</sup></i> Knock-In Mice
Background: The endocannabinoid system (ECS) and associated lipid transmitter-based signaling systems play an important role in modulating brain neuroinflammation. ECS is affected in neurodegenerative disorders, such as Alzheimer’s disease (AD). Here we have evaluated the non-psychotropic endocannab...
Main Authors: | Dina Medina-Vera, Hongjing Zhao, Erika Bereczki, Cristina Rosell-Valle, Makoto Shimozawa, Gefei Chen, Fernando Rodríguez de Fonseca, Per Nilsson, Simone Tambaro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/6/805 |
Similar Items
-
CB2 and GPR55 receptors as therapeutic targets for systemic immune dysregulation
by: Juan Zhou, et al.
Published: (2016-08-01) -
Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
by: Raquel Guerrero-Alba, et al.
Published: (2019-01-01) -
The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells
by: Mikhail G. Akimov, et al.
Published: (2023-03-01) -
Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors
by: Lizbeth Magnolia Martínez-Aguilar, et al.
Published: (2023-03-01) -
The Endocannabinoid System and Invertebrate Neurodevelopment and Regeneration
by: Tristyn L. Clarke, et al.
Published: (2021-02-01)